Vyome (NASDAQ:HIND) Announces Earnings Results

Vyome (NASDAQ:HIND) posted its quarterly earnings results on Tuesday. The company reported ($0.15) earnings per share (EPS) for the quarter, Zacks reports. Vyome had a negative net margin of 270.58% and a negative return on equity of 279.99%.

Vyome Price Performance

Shares of HIND traded up $0.01 during mid-day trading on Tuesday, reaching $1.98. The company’s stock had a trading volume of 241,894 shares, compared to its average volume of 600,012. Vyome has a 12-month low of $1.75 and a 12-month high of $33.16. The stock has a market cap of $13.90 million, a PE ratio of -0.02 and a beta of 1.38. The company’s 50 day moving average is $2.32 and its 200 day moving average is $3.40.

Analyst Ratings Changes

Several brokerages recently weighed in on HIND. Litchfield Hills Research initiated coverage on shares of Vyome in a report on Monday, May 4th. They issued a “buy” rating on the stock. Weiss Ratings raised shares of Vyome from a “sell (e)” rating to a “sell (e+)” rating in a research report on Friday, May 1st. Finally, Zacks Research upgraded shares of Vyome to a “hold” rating in a report on Wednesday, May 6th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Vyome presently has an average rating of “Hold” and an average target price of $15.00.

Institutional Investors Weigh In On Vyome

An institutional investor recently bought a new position in Vyome stock. Millennium Management LLC bought a new stake in Vyome Holdings, Inc. (NASDAQ:HIND) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 45,144 shares of the company’s stock, valued at approximately $155,000. Millennium Management LLC owned about 0.80% of Vyome as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 22.06% of the company’s stock.

About Vyome

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.